PritorPlus

Country: Evrópusambandið

Tungumál: enska

Heimild: EMA (European Medicines Agency)

Kauptu það núna

Vara einkenni Vara einkenni (SPC)
14-09-2022
Opinber matsskýrsla Opinber matsskýrsla (PAR)
12-11-2015

Virkt innihaldsefni:

Telmisartan, hydrochlorothiazide

Fáanlegur frá:

Bayer AG

ATC númer:

C09DA07

INN (Alþjóðlegt nafn):

telmisartan, hydrochlorothiazide

Meðferðarhópur:

Agents acting on the renin-angiotensin system

Lækningarsvæði:

Hypertension

Ábendingar:

Treatment of essential hypertension.PritorPlus fixed-dose combination (40 mg telmisartan / 12.5 mg hydrochlorothiazide, 80mg telmisartan / 12.5 mg hydrochlorothiazide) is indicated in patients whose blood pressure is not adequately controlled on telmisartan alone.PritorPlus fixed-dose combination (80 mg telmisartan / 25 mg hydrochlorothiazide) is indicated in patients whose blood pressure is not adequately controlled on PritorPlus (80 mg telmisartan / 12.5 mg hydrochlorothiazide) or patients who have been previously stabilised on telmisartan and hydrochlorothiazide given separately.

Vörulýsing:

Revision: 37

Leyfisstaða:

Authorised

Leyfisdagur:

2002-04-22

Upplýsingar fylgiseðill

                                59
B. PACKAGE LEAFLET
60
PACKAGE LEAFLET: INFORMATION FOR THE USER
PRITORPLUS 40 MG/12.5 MG TABLETS
telmisartan/hydrochlorothiazide
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What PritorPlus is and what it is used for
2.
What you need to know before you take PritorPlus
3.
How to take PritorPlus
4.
Possible side effects
5.
How to store PritorPlus
6.
Contents of the pack and other information
1.
WHAT PRITORPLUS IS AND WHAT IT IS USED FOR
PritorPlus is a combination of two active substances, telmisartan and
hydrochlorothiazide in one
tablet. Both of these substances help to control high blood pressure.
-
Telmisartan belongs to a group of medicines called angiotensin II
receptor antagonists.
Angiotensin-II is a substance produced in your body which causes your
blood vessels to narrow
thus increasing your blood pressure. Telmisartan blocks the effect of
angiotensin II so that the
blood vessels relax, and your blood pressure is lowered.
-
Hydrochlorothiazide belongs to a group of medicines called thiazide
diuretics, which cause your
urine output to increase, leading to a lowering of your blood
pressure.
High blood pressure, if not treated, can damage blood vessels in
several organs, which could lead
sometimes to heart attack, heart or kidney failure, stroke, or
blindness. There are usually no symptoms
of high blood pressure before damage occurs. Thus it is important to
regularly measure blood pressure
to verify if it is within the normal range.
PritorPlus is used to treat high blood pressure (essential
                                
                                Lestu allt skjalið
                                
                            

Vara einkenni

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
PritorPlus 40 mg/12.5 mg tablets
PritorPlus 80 mg/12.5 mg tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
PritorPlus 40 mg/12.5 mg tablets
Each tablet contains 40 mg telmisartan and 12.5 mg
hydrochlorothiazide.
PritorPlus 80 mg/12.5 mg tablets
Each tablet contains 80 mg telmisartan and 12.5 mg
hydrochlorothiazide.
Excipients with known effect
PritorPlus 40 mg/12.5 mg tablets
Each tablet contains 112 mg of lactose monohydrate equivalent to 107
mg lactose anhydrous.
Each tablet contains 169 mg sorbitol (E420).
PritorPlus 80 mg/12.5 mg tablets
Each tablet contains 112 mg of lactose monohydrate equivalent to 107
mg lactose anhydrous.
Each tablet contains 338 mg sorbitol (E420).
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
PritorPlus 40 mg/12.5 mg tablets
Red and white oblong shaped two layer tablet of 5.2 mm engraved with
the code number 'H4'.
PritorPlus 80 mg/12.5 mg tablets
Red and white oblong shaped two layer tablet of 6.2 mm engraved with
the code number 'H8'.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Treatment of essential hypertension.
PritorPlus fixed dose combination (40 mg telmisartan/12.5 mg
hydrochlorothiazide (HCTZ) and
80 mg telmisartan/12.5 mg HCTZ) is indicated in adults whose blood
pressure is not adequately
controlled on telmisartan alone.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
The fixed dose combination should be taken in patients whose blood
pressure is not adequately
controlled by telmisartan alone. Individual dose titration with each
of the two components is
recommended before changing to the fixed dose combination. When
clinically appropriate, direct
change from monotherapy to the fixed combination may be considered.
3
•
PritorPlus 40 mg/12.5 mg may be administered once daily in patients
whose blood pressure is
not adequately controlled by Pritor 40 mg
•
PritorPlus 80 mg/12.5 mg may be administered once daily in patients
whose blood pressure is
not ad
                                
                                Lestu allt skjalið
                                
                            

Skjöl á öðrum tungumálum

Upplýsingar fylgiseðill Upplýsingar fylgiseðill búlgarska 14-09-2022
Vara einkenni Vara einkenni búlgarska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla búlgarska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill spænska 14-09-2022
Vara einkenni Vara einkenni spænska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla spænska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill tékkneska 14-09-2022
Vara einkenni Vara einkenni tékkneska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla tékkneska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill danska 14-09-2022
Vara einkenni Vara einkenni danska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla danska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill þýska 14-09-2022
Vara einkenni Vara einkenni þýska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla þýska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill eistneska 14-09-2022
Vara einkenni Vara einkenni eistneska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla eistneska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill gríska 14-09-2022
Vara einkenni Vara einkenni gríska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla gríska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill franska 14-09-2022
Vara einkenni Vara einkenni franska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla franska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill ítalska 14-09-2022
Vara einkenni Vara einkenni ítalska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla ítalska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill lettneska 14-09-2022
Vara einkenni Vara einkenni lettneska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla lettneska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill litháíska 14-09-2022
Vara einkenni Vara einkenni litháíska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla litháíska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill ungverska 14-09-2022
Vara einkenni Vara einkenni ungverska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla ungverska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill maltneska 14-09-2022
Vara einkenni Vara einkenni maltneska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla maltneska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill hollenska 14-09-2022
Vara einkenni Vara einkenni hollenska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla hollenska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill pólska 14-09-2022
Vara einkenni Vara einkenni pólska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla pólska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill portúgalska 14-09-2022
Vara einkenni Vara einkenni portúgalska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla portúgalska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill rúmenska 14-09-2022
Vara einkenni Vara einkenni rúmenska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla rúmenska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill slóvakíska 14-09-2022
Vara einkenni Vara einkenni slóvakíska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla slóvakíska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill slóvenska 14-09-2022
Vara einkenni Vara einkenni slóvenska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla slóvenska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill finnska 14-09-2022
Vara einkenni Vara einkenni finnska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla finnska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill sænska 14-09-2022
Vara einkenni Vara einkenni sænska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla sænska 12-11-2015
Upplýsingar fylgiseðill Upplýsingar fylgiseðill norska 14-09-2022
Vara einkenni Vara einkenni norska 14-09-2022
Upplýsingar fylgiseðill Upplýsingar fylgiseðill íslenska 14-09-2022
Vara einkenni Vara einkenni íslenska 14-09-2022
Upplýsingar fylgiseðill Upplýsingar fylgiseðill króatíska 14-09-2022
Vara einkenni Vara einkenni króatíska 14-09-2022
Opinber matsskýrsla Opinber matsskýrsla króatíska 12-11-2015

Leitaðu viðvaranir sem tengjast þessari vöru

Skoða skjalasögu